- REPORT SUMMARY
- TABLE OF CONTENTS
-
Short Bowel Syndrome market report explains the definition, types, applications, major countries, and major players of the Short Bowel Syndrome market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Merck
Zealand Pharma
OxThera
GlyPharma Therapeutics
Sancilio & Company
Emmaus Life Sciences
Naia Pharmaceuticals
Ardelyx
Nutrinia
Shire
By Type:
GLP-2
Growth Hormone
Glutamine
Others
By End-User:
Hospitals
Clinics
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Short Bowel Syndrome Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Short Bowel Syndrome Outlook to 2028- Original Forecasts
-
2.2 Short Bowel Syndrome Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Short Bowel Syndrome Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Short Bowel Syndrome Market- Recent Developments
-
6.1 Short Bowel Syndrome Market News and Developments
-
6.2 Short Bowel Syndrome Market Deals Landscape
7 Short Bowel Syndrome Raw Materials and Cost Structure Analysis
-
7.1 Short Bowel Syndrome Key Raw Materials
-
7.2 Short Bowel Syndrome Price Trend of Key Raw Materials
-
7.3 Short Bowel Syndrome Key Suppliers of Raw Materials
-
7.4 Short Bowel Syndrome Market Concentration Rate of Raw Materials
-
7.5 Short Bowel Syndrome Cost Structure Analysis
-
7.5.1 Short Bowel Syndrome Raw Materials Analysis
-
7.5.2 Short Bowel Syndrome Labor Cost Analysis
-
7.5.3 Short Bowel Syndrome Manufacturing Expenses Analysis
8 Global Short Bowel Syndrome Import and Export Analysis (Top 10 Countries)
-
8.1 Global Short Bowel Syndrome Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Short Bowel Syndrome Export by Region (Top 10 Countries) (2017-2028)
9 Global Short Bowel Syndrome Market Outlook by Types and Applications to 2022
-
9.1 Global Short Bowel Syndrome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GLP-2 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glutamine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Short Bowel Syndrome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Short Bowel Syndrome Market Analysis and Outlook till 2022
-
10.1 Global Short Bowel Syndrome Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Short Bowel Syndrome Consumption (2017-2022)
-
10.2.2 Canada Short Bowel Syndrome Consumption (2017-2022)
-
10.2.3 Mexico Short Bowel Syndrome Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Short Bowel Syndrome Consumption (2017-2022)
-
10.3.2 UK Short Bowel Syndrome Consumption (2017-2022)
-
10.3.3 Spain Short Bowel Syndrome Consumption (2017-2022)
-
10.3.4 Belgium Short Bowel Syndrome Consumption (2017-2022)
-
10.3.5 France Short Bowel Syndrome Consumption (2017-2022)
-
10.3.6 Italy Short Bowel Syndrome Consumption (2017-2022)
-
10.3.7 Denmark Short Bowel Syndrome Consumption (2017-2022)
-
10.3.8 Finland Short Bowel Syndrome Consumption (2017-2022)
-
10.3.9 Norway Short Bowel Syndrome Consumption (2017-2022)
-
10.3.10 Sweden Short Bowel Syndrome Consumption (2017-2022)
-
10.3.11 Poland Short Bowel Syndrome Consumption (2017-2022)
-
10.3.12 Russia Short Bowel Syndrome Consumption (2017-2022)
-
10.3.13 Turkey Short Bowel Syndrome Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Short Bowel Syndrome Consumption (2017-2022)
-
10.4.2 Japan Short Bowel Syndrome Consumption (2017-2022)
-
10.4.3 India Short Bowel Syndrome Consumption (2017-2022)
-
10.4.4 South Korea Short Bowel Syndrome Consumption (2017-2022)
-
10.4.5 Pakistan Short Bowel Syndrome Consumption (2017-2022)
-
10.4.6 Bangladesh Short Bowel Syndrome Consumption (2017-2022)
-
10.4.7 Indonesia Short Bowel Syndrome Consumption (2017-2022)
-
10.4.8 Thailand Short Bowel Syndrome Consumption (2017-2022)
-
10.4.9 Singapore Short Bowel Syndrome Consumption (2017-2022)
-
10.4.10 Malaysia Short Bowel Syndrome Consumption (2017-2022)
-
10.4.11 Philippines Short Bowel Syndrome Consumption (2017-2022)
-
10.4.12 Vietnam Short Bowel Syndrome Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Short Bowel Syndrome Consumption (2017-2022)
-
10.5.2 Colombia Short Bowel Syndrome Consumption (2017-2022)
-
10.5.3 Chile Short Bowel Syndrome Consumption (2017-2022)
-
10.5.4 Argentina Short Bowel Syndrome Consumption (2017-2022)
-
10.5.5 Venezuela Short Bowel Syndrome Consumption (2017-2022)
-
10.5.6 Peru Short Bowel Syndrome Consumption (2017-2022)
-
10.5.7 Puerto Rico Short Bowel Syndrome Consumption (2017-2022)
-
10.5.8 Ecuador Short Bowel Syndrome Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Short Bowel Syndrome Consumption (2017-2022)
-
10.6.2 Kuwait Short Bowel Syndrome Consumption (2017-2022)
-
10.6.3 Oman Short Bowel Syndrome Consumption (2017-2022)
-
10.6.4 Qatar Short Bowel Syndrome Consumption (2017-2022)
-
10.6.5 Saudi Arabia Short Bowel Syndrome Consumption (2017-2022)
-
10.6.6 United Arab Emirates Short Bowel Syndrome Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Short Bowel Syndrome Consumption (2017-2022)
-
10.7.2 South Africa Short Bowel Syndrome Consumption (2017-2022)
-
10.7.3 Egypt Short Bowel Syndrome Consumption (2017-2022)
-
10.7.4 Algeria Short Bowel Syndrome Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Short Bowel Syndrome Consumption (2017-2022)
-
10.8.2 New Zealand Short Bowel Syndrome Consumption (2017-2022)
11 Global Short Bowel Syndrome Competitive Analysis
-
11.1 Merck
-
11.1.1 Merck Company Details
-
11.1.2 Merck Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Merck Short Bowel Syndrome Main Business and Markets Served
-
11.1.4 Merck Short Bowel Syndrome Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Zealand Pharma
-
11.2.1 Zealand Pharma Company Details
-
11.2.2 Zealand Pharma Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Zealand Pharma Short Bowel Syndrome Main Business and Markets Served
-
11.2.4 Zealand Pharma Short Bowel Syndrome Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 OxThera
-
11.3.1 OxThera Company Details
-
11.3.2 OxThera Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 OxThera Short Bowel Syndrome Main Business and Markets Served
-
11.3.4 OxThera Short Bowel Syndrome Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 GlyPharma Therapeutics
-
11.4.1 GlyPharma Therapeutics Company Details
-
11.4.2 GlyPharma Therapeutics Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 GlyPharma Therapeutics Short Bowel Syndrome Main Business and Markets Served
-
11.4.4 GlyPharma Therapeutics Short Bowel Syndrome Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Sancilio & Company
-
11.5.1 Sancilio & Company Company Details
-
11.5.2 Sancilio & Company Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Sancilio & Company Short Bowel Syndrome Main Business and Markets Served
-
11.5.4 Sancilio & Company Short Bowel Syndrome Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Emmaus Life Sciences
-
11.6.1 Emmaus Life Sciences Company Details
-
11.6.2 Emmaus Life Sciences Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Emmaus Life Sciences Short Bowel Syndrome Main Business and Markets Served
-
11.6.4 Emmaus Life Sciences Short Bowel Syndrome Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Naia Pharmaceuticals
-
11.7.1 Naia Pharmaceuticals Company Details
-
11.7.2 Naia Pharmaceuticals Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Naia Pharmaceuticals Short Bowel Syndrome Main Business and Markets Served
-
11.7.4 Naia Pharmaceuticals Short Bowel Syndrome Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Ardelyx
-
11.8.1 Ardelyx Company Details
-
11.8.2 Ardelyx Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Ardelyx Short Bowel Syndrome Main Business and Markets Served
-
11.8.4 Ardelyx Short Bowel Syndrome Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Nutrinia
-
11.9.1 Nutrinia Company Details
-
11.9.2 Nutrinia Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Nutrinia Short Bowel Syndrome Main Business and Markets Served
-
11.9.4 Nutrinia Short Bowel Syndrome Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Shire
-
11.10.1 Shire Company Details
-
11.10.2 Shire Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Shire Short Bowel Syndrome Main Business and Markets Served
-
11.10.4 Shire Short Bowel Syndrome Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Short Bowel Syndrome Market Outlook by Types and Applications to 2028
-
12.1 Global Short Bowel Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Short Bowel Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Short Bowel Syndrome Market Analysis and Outlook to 2028
-
13.1 Global Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.2.2 Canada Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.2.3 Mexico Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.2 UK Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.3 Spain Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.4 Belgium Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.5 France Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.6 Italy Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.7 Denmark Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.8 Finland Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.9 Norway Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.10 Sweden Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.11 Poland Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.12 Russia Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.13 Turkey Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.2 Japan Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.3 India Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.4 South Korea Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.8 Thailand Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.9 Singapore Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.11 Philippines Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.2 Colombia Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.3 Chile Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.4 Argentina Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.6 Peru Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.3 Oman Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.4 Qatar Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7.2 South Africa Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7.3 Egypt Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7.4 Algeria Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Short Bowel Syndrome Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Short Bowel Syndrome
-
Figure of Short Bowel Syndrome Picture
-
Table Global Short Bowel Syndrome Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Short Bowel Syndrome Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global GLP-2 Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Short Bowel Syndrome Consumption by Country (2017-2022)
-
Table North America Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure United States Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Canada Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Mexico Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Europe Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Germany Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure UK Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Spain Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Belgium Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure France Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Italy Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Denmark Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Finland Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Norway Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Sweden Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Poland Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Russia Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Turkey Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table APAC Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure China Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Japan Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure India Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Thailand Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Singapore Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Philippines Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table South America Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Brazil Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Colombia Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Chile Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Argentina Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Peru Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table GCC Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Bahrain Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Oman Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Qatar Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Africa Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Nigeria Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Africa Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Egypt Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Algeria Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Oceania Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Australia Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Merck Company Details
-
Table Merck Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Short Bowel Syndrome Main Business and Markets Served
-
Table Merck Short Bowel Syndrome Product Portfolio
-
Table Zealand Pharma Company Details
-
Table Zealand Pharma Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zealand Pharma Short Bowel Syndrome Main Business and Markets Served
-
Table Zealand Pharma Short Bowel Syndrome Product Portfolio
-
Table OxThera Company Details
-
Table OxThera Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table OxThera Short Bowel Syndrome Main Business and Markets Served
-
Table OxThera Short Bowel Syndrome Product Portfolio
-
Table GlyPharma Therapeutics Company Details
-
Table GlyPharma Therapeutics Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlyPharma Therapeutics Short Bowel Syndrome Main Business and Markets Served
-
Table GlyPharma Therapeutics Short Bowel Syndrome Product Portfolio
-
Table Sancilio & Company Company Details
-
Table Sancilio & Company Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sancilio & Company Short Bowel Syndrome Main Business and Markets Served
-
Table Sancilio & Company Short Bowel Syndrome Product Portfolio
-
Table Emmaus Life Sciences Company Details
-
Table Emmaus Life Sciences Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Life Sciences Short Bowel Syndrome Main Business and Markets Served
-
Table Emmaus Life Sciences Short Bowel Syndrome Product Portfolio
-
Table Naia Pharmaceuticals Company Details
-
Table Naia Pharmaceuticals Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Naia Pharmaceuticals Short Bowel Syndrome Main Business and Markets Served
-
Table Naia Pharmaceuticals Short Bowel Syndrome Product Portfolio
-
Table Ardelyx Company Details
-
Table Ardelyx Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ardelyx Short Bowel Syndrome Main Business and Markets Served
-
Table Ardelyx Short Bowel Syndrome Product Portfolio
-
Table Nutrinia Company Details
-
Table Nutrinia Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nutrinia Short Bowel Syndrome Main Business and Markets Served
-
Table Nutrinia Short Bowel Syndrome Product Portfolio
-
Table Shire Company Details
-
Table Shire Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Short Bowel Syndrome Main Business and Markets Served
-
Table Shire Short Bowel Syndrome Product Portfolio
-
Figure Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Table North America Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure United States Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Germany Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure China Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Brazil Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Australia Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-